Antidote Financials

£2.4 M

Revenue FY, 2016
Gross profit (FY, 2016)1.3 M
Gross profit margin (FY, 2016), %53%
Net income (FY, 2016)-3.3 M
EBITDA (FY, 2016)-3.6 M
EBIT (FY, 2016)-3.7 M
Cash, 31-Dec-20162.3 M

Capital Structure

Summary Metrics

Founding Date

2009

Total Funding

$17.9 m

Latest funding size

$13.50 m

Time since last funding

3 years ago

Investors

Antidote's latest funding round in February 2015 was reported to be $13.5 m. In total, Antidote has raised $17.9 m

Capital Raised

Embed Graph

Revenue/Financials

Income Statement

Annual

GBPFY, 2015FY, 2016

Revenue

2.2 m2.4 m

Cost of goods sold

912.3 k1.1 m

Gross profit

1.3 m1.3 m

Gross profit Margin, %

59%53%

Operating expense total

3.8 m4.9 m

EBITDA

(2.5 m)(3.6 m)

EBITDA margin, %

(110%)(151%)

EBIT

(2.5 m)(3.7 m)

EBIT margin, %

(110%)(152%)

Pre tax profit

(2.5 m)(3.7 m)

Income tax expense

218.5 k375.3 k

Net Income

(2.2 m)(3.3 m)

Balance Sheet

Annual

GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

284.3 k1.9 m147.5 k1.3 m2.3 m

Accounts Receivable

73.1 k211.4 k504.2 k647.1 k967.5 k

Current Assets

357.4 k2.1 m651.8 k2.2 m3.7 m

PP&E

1.5 k6.7 k14.9 k85.5 k77 k

Total Assets

388.1 k2.1 m666.7 k2.4 m3.9 m

Accounts Payable

23.9 k61.6 k1 m226.3 k77.5 k

Current Liabilities

23.9 k61.6 k1 m442.1 k638.8 k

Non-Current Liabilities

54 k132.5 k

Total Liabilities

23.9 k61.6 k1 m496 k771.4 k

Additional Paid-in Capital

43 k45.1 k44.3 k45 k45.9 k

Retained Earnings

(2.2 m)(3.3 m)

Total Equity

364.2 k2.1 m(363.4 k)1.9 m3.1 m

Financial Leverage

1.1 x1 x-1.8 x1.3 x1.2 x

Cash Flow

Annual

GBPFY, 2015FY, 2016

Net Income

(2.2 m)(3.3 m)

Ratios

GBPY, 2016

Revenue/Employee

46.2 k

Financial Leverage

1.2 x
Report incorrect company information